Drug details
Vyjuvek (beremagene geperpavec topical gel)
type of Dermatologics, Other
Vyjuvek (beremagene geperpavec-svdt) is a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.
This drug may have the following side effects:
- itching,
- rash,
- chills,
- redness,
- cough, and
- runny nose.